Literature DB >> 17304707

Mumps virus vaccines.

.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17304707

Source DB:  PubMed          Journal:  Wkly Epidemiol Rec        ISSN： 0049-8114


× No keyword cloud information.
  22 in total

1.  Assessment of mumps virus-specific antibodies by different serological assays: which test correlates best with mumps immunity?

Authors:  R Allwinn; B Zeidler; K Steinhagen; E Rohwäder; S Wicker; H F Rabenau; H W Doerr
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2011-04-01       Impact factor: 3.267

2.  Update on available vaccines in India: report of the APPA VU 2010: I.

Authors:  Sunil Karande
Journal:  Indian J Pediatr       Date:  2011-03-05       Impact factor: 1.967

3.  Monitoring Viral Genetic Variation as a Tool To Improve Molecular Diagnostics for Mumps Virus.

Authors:  Meik Dilcher; Kevin Barratt; Jennifer Douglas; Andrew Strathdee; Trevor Anderson; Anja Werno
Journal:  J Clin Microbiol       Date:  2018-09-25       Impact factor: 5.948

4.  Viral etiology of mumps-like illnesses in suspected mumps cases reported in Catalonia, Spain.

Authors:  Irene Barrabeig; Josep Costa; Ariadna Rovira; M Angeles Marcos; Ricard Isanta; Rubén López-Adalid; Ana Cervilla; Nuria Torner; Angela Domínguez
Journal:  Hum Vaccin Immunother       Date:  2014-11-01       Impact factor: 3.452

5.  Mumps virus pathogenesis: Insights and knowledge gaps.

Authors:  Sigrid Gouma; Marion P G Koopmans; Rob S van Binnendijk
Journal:  Hum Vaccin Immunother       Date:  2016-07-25       Impact factor: 3.452

6.  Anti-mumps virus activity by extracts of Mimosa pudica, a unique Indian medicinal plant.

Authors:  Jeevan Malayan; Balaji Selvaraj; Aparna Warrier; Sambantham Shanmugam; Manikannan Mathayan; Thangam Menon
Journal:  Indian J Virol       Date:  2013-08-10

7.  Persistence of antibodies induced by measles-mumps-rubella vaccine in children in India.

Authors:  S K Raut; P S Kulkarni; M A Phadke; S S Jadhav; S V Kapre; R M Dhere; S P Dhorje; S R Godse
Journal:  Clin Vaccine Immunol       Date:  2007-08-15

8.  Seroprevalence and Determinants Associated with Mumps Antibodies after 20 Years of MMR Vaccination in Urban Area of Shanghai, China.

Authors:  Hong Pang; Yibiao Zhou; Wensui Zhao; Qingwu Jiang
Journal:  Int J Environ Res Public Health       Date:  2018-09-23       Impact factor: 3.390

9.  Enhancing global vaccine pharmacovigilance: Proof-of-concept study on aseptic meningitis and immune thrombocytopenic purpura following measles-mumps containing vaccination.

Authors:  Silvia Perez-Vilar; Daniel Weibel; Miriam Sturkenboom; Steven Black; Christine Maure; Jose Luis Castro; Pamela Bravo-Alcántara; Caitlin N Dodd; Silvana A Romio; Maria de Ridder; Swabra Nakato; Helvert Felipe Molina-León; Varalakshmi Elango; Patrick L F Zuber
Journal:  Vaccine       Date:  2017-05-27       Impact factor: 3.641

10.  Loss of protective immunity of two-dose mumps-containing vaccine over time: concerns with the new strategy of the mumps immunization program in China.

Authors:  Danni Wang; Tingyue Nie; Fan Pan; Yao Wang; Jian Wang; Wei Qin
Journal:  Hum Vaccin Immunother       Date:  2021-02-05       Impact factor: 3.452
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.